Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioLiberty

Request full access

Soft robotic upper-limb rehabilitation for stroke patients

Edinburgh, United KingdomFounded 2020Health Tech & Medtech
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for BioLiberty and the history behind them.

About BioLiberty

Bioliberty is an Edinburgh- and Boston-based healthtech company that develops rehabilitation technology for people recovering from stroke and other neurological conditions. It focuses on upper-limb therapy, combining soft robotic wearables, gamified exercises and AI-powered insights so therapists can deliver more high-intensity therapy to more patients.

Its main product is the Lifehub Clinic system for inpatient and outpatient care. The Lifehub control unit runs the therapy interface and powers Lifeglov, an air-powered soft robotic glove that supports hand extension and repeated, controlled movement. Lifemind, the clinician interface, gathers the therapy data captured by Lifehub so therapists can track progress, adjust treatment and document care. The company is adding computer vision and care coordination features and developing Lifehub Home to continue therapy in patients' homes after in-person rehabilitation ends.

Bioliberty sells Lifehub Clinic to healthcare facilities such as rehabilitation hospitals, post-acute care providers and therapy clinics in the US and UK, and runs clinical studies with partner hospitals.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Edinburgh, United Kingdom
Sector
Health Tech & Medtech

BioLiberty in the Edinburgh ecosystem

Live from Dealroom

The BioLiberty office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

  • CO-FOUNDERS
  • Catalyst Belfast Fintech Hub
  • Scottish Enterprise Growth Investments
  • Archangels
  • Eos Advisory
  • Hanna Capital SEZC
  • Edinburgh Innovations

Series A4 investors entered at this stage

  • University of Edinburgh
  • Scottish National Investment Bank
  • Old College Capital
  • The Conduit Connect
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom67.9%
🇺🇸 United States32.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioLiberty on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioLiberty on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.